Martín Lázaro Quintela

Real world data of nivolumab for previously treated non-small cell lung cancer patients: a Galician lung cancer group clinical experience

Ma Carmen Areses Manrique, Joaquín Mosquera, Jorge García et al. · Translational Lung Cancer Research · 2018 · 63 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium (IMDC) prognostic model for first-line pazopanib in metastatic renal carcinoma: the Spanish Oncologic Genitourinary Group (SOGUG) SPAZO study

Begoña Pérez‐Valderrama, Jóse Ángel Arranz Arija, Ángel Rodríguez Sánchez et al. · Annals of Oncology · 2015 · 37 citations · Full text

Medicine, Oncology, Pharmacology +15

Epacadostat plus pembrolizumab versus placebo plus pembrolizumab as first-line treatment for metastatic non-small cell lung cancer with high levels of programmed death-ligand 1: a randomized, double-blind phase 2 study

Takaaki Tokito, Jens Christian Hedemann Sørensen, Mehmet Artaç et al. · BMC Cancer · 2024 · 10 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17